The Oncology Institute, Inc. (TOI)
NASDAQ: TOI · Real-Time Price · USD
3.440
+0.110 (3.30%)
At close: Apr 28, 2026, 4:00 PM EDT
3.430
-0.010 (-0.29%)
After-hours: Apr 28, 2026, 5:26 PM EDT
The Oncology Institute Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2018 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2018 |
| Revenue | 502.73 | 393.41 | 324.24 | 252.48 | 203 | Upgrade
|
| Revenue Growth (YoY) | 27.79% | 21.33% | 28.42% | 24.37% | 8.26% | Upgrade
|
| Cost of Revenue | 426.29 | 339.42 | 264.67 | 200.39 | 162.16 | Upgrade
|
| Gross Profit | 76.44 | 54 | 59.57 | 52.09 | 40.85 | Upgrade
|
| Selling, General & Admin | 105.57 | 107.83 | 113.85 | 119.69 | 82.89 | Upgrade
|
| Operating Expenses | 112.52 | 114.12 | 119.72 | 124.1 | 86.23 | Upgrade
|
| Operating Income | -36.08 | -60.12 | -60.15 | -72.01 | -45.38 | Upgrade
|
| Interest Expense | -11.28 | -7.5 | -6.78 | -4.08 | -0.32 | Upgrade
|
| Other Non Operating Income (Expenses) | -13.38 | 2.82 | -0.35 | 25.9 | 3.71 | Upgrade
|
| EBT Excluding Unusual Items | -60.74 | -64.8 | -67.28 | -50.19 | -41.99 | Upgrade
|
| Merger & Restructuring Charges | - | - | - | - | -0.48 | Upgrade
|
| Impairment of Goodwill | - | - | -16.87 | -9.94 | - | Upgrade
|
| Gain (Loss) on Sale of Investments | 0.01 | 0.13 | 0.24 | 0.64 | - | Upgrade
|
| Other Unusual Items | - | - | 0.8 | 59.4 | 30.87 | Upgrade
|
| Pretax Income | -60.74 | -64.66 | -83.1 | -0.09 | -11.6 | Upgrade
|
| Income Tax Expense | -0.13 | - | -0.04 | -0.24 | -0.67 | Upgrade
|
| Net Income | -60.61 | -64.66 | -83.07 | 0.15 | -10.93 | Upgrade
|
| Preferred Dividends & Other Adjustments | -10.3 | -11.66 | -15.19 | 0.08 | -0.3 | Upgrade
|
| Net Income to Common | -50.31 | -53.01 | -67.88 | 0.07 | -10.63 | Upgrade
|
| Shares Outstanding (Basic) | 92 | 75 | 74 | 73 | 66 | Upgrade
|
| Shares Outstanding (Diluted) | 92 | 75 | 74 | 81 | 66 | Upgrade
|
| Shares Change (YoY) | 23.11% | 1.76% | -8.51% | 21.70% | 12.03% | Upgrade
|
| EPS (Basic) | -0.54 | -0.71 | -0.92 | 0.00 | -0.16 | Upgrade
|
| EPS (Diluted) | -0.54 | -0.71 | -0.92 | -0.21 | -0.16 | Upgrade
|
| Free Cash Flow | -27.79 | -30.33 | -40.88 | -67.29 | -35.53 | Upgrade
|
| Free Cash Flow Per Share | -0.30 | -0.40 | -0.55 | -0.83 | -0.54 | Upgrade
|
| Gross Margin | 15.20% | 13.73% | 18.37% | 20.63% | 20.12% | Upgrade
|
| Operating Margin | -7.18% | -15.28% | -18.55% | -28.52% | -22.36% | Upgrade
|
| Profit Margin | -10.01% | -13.47% | -20.93% | 0.03% | -5.24% | Upgrade
|
| Free Cash Flow Margin | -5.53% | -7.71% | -12.61% | -26.65% | -17.50% | Upgrade
|
| EBITDA | -29.14 | -53.83 | -54.28 | -67.6 | -42.04 | Upgrade
|
| EBITDA Margin | -5.80% | -13.68% | -16.74% | -26.77% | -20.71% | Upgrade
|
| D&A For EBITDA | 6.94 | 6.29 | 5.87 | 4.41 | 3.34 | Upgrade
|
| EBIT | -36.08 | -60.12 | -60.15 | -72.01 | -45.38 | Upgrade
|
| EBIT Margin | -7.18% | -15.28% | -18.55% | -28.52% | -22.36% | Upgrade
|
| Revenue as Reported | 502.73 | 393.41 | 324.24 | 252.48 | 203 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.